GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
GlobeNewswire
· *Ipsen’s Iqirvo*^*®** (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for..
